UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biochemical and biophysical research communications, ISSN 0006-291X, 09/2018, Volume 503, Issue 2, pp. 677 - 683
PEGylated liposomes | Lapatinib | Chorioallantoic membrane | HER2 receptor | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Cardiotoxicity - etiology | Antineoplastic Agents - administration & dosage | Lapatinib - toxicity | Antineoplastic Agents - toxicity | Breast Neoplasms - metabolism | Lapatinib - pharmacology | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Cardiotoxicity - prevention & control | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Lapatinib - therapeutic use | Breast Neoplasms - drug therapy | Chick Embryo | Protein Kinase Inhibitors - administration & dosage | Liposomes - chemistry | Animals | Breast Neoplasms - pathology | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Protein Kinase Inhibitors - toxicity | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Lapatinib - administration & dosage | Care and treatment | Epidermal growth factor | Polyethylene glycol | Analysis | Cancer | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 10/2018, Volume 19, Issue 10, p. 3069
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 4/2018, Volume 168, Issue 3, pp. 631 - 638
Brain natriuretic peptide | Medicine & Public Health | HER2 positive breast cancer | Oncology | Lapatinib | Cardiotoxicity | Troponin T | Life Sciences & Biomedicine | Science & Technology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Cardiovascular Abnormalities - blood | Cardiotoxicity - pathology | Cardiovascular Abnormalities - pathology | Troponin T - blood | Drug-Related Side Effects and Adverse Reactions | Female | Paclitaxel - administration & dosage | Natriuretic Peptide, Brain - blood | Lapatinib - adverse effects | Cardiotoxicity - blood | Paclitaxel - adverse effects | Trastuzumab - adverse effects | Trastuzumab - administration & dosage | Biomarkers - blood | Breast Neoplasms - drug therapy | Breast Neoplasms - complications | Breast Neoplasms - pathology | Cardiovascular Abnormalities - chemically induced | Breast Neoplasms - blood | Aged | Neoplasm Staging | Lapatinib - administration & dosage | Complications and side effects | Care and treatment | Anthracyclines | Oncology, Experimental | Breast cancer | Research | Biological markers | Cancer | Natriuretic peptides | Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 02/2019, Volume 295, pp. 223 - 236
Nanoparticles | Polymer | Drug delivery | Prodrug | Combination therapy | Cancer | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Prodrugs - administration & dosage | Cell Survival - drug effects | Deoxycytidine - chemistry | Nanoparticles - chemistry | Deoxycytidine - administration & dosage | Humans | Lapatinib - chemistry | Polymerization | Deoxycytidine - pharmacology | Doxorubicin - chemistry | Prodrugs - chemistry | Breast Neoplasms - drug therapy | Drug Carriers - chemistry | Drug Synergism | Lapatinib - pharmacology | MCF-7 Cells | Female | Prodrugs - pharmacology | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology | Drug Combinations | Doxorubicin - administration & dosage | Lapatinib - administration & dosage | Index Medicus | Medicinal Chemistry | Life Sciences | Polymers | Galenic pharmacology | Chemical Sciences | Pharmaceutical sciences
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 8/2019, Volume 84, Issue 2, pp. 383 - 392
QTc effects | Medicine & Public Health | Oncology | Cancer Research | Advanced cancer patients | Lapatinib | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Lapatinib - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Cross-Over Studies | Lapatinib - pharmacology | Young Adult | Aged, 80 and over | Adult | Female | Aged | Antineoplastic Agents - pharmacology | Neoplasms - pathology | Chemotherapy | Pharmacology | Solid tumors | Crossovers | Cancer | Tumors | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 11/2019, Volume 178, Issue 1, pp. 239 - 244
Oncology | Lapatinib | Medicine & Public Health | Hepatotoxicity | H2 blocker | CYP3A4 inducer | Life Sciences & Biomedicine | Science & Technology | Multivariate Analysis | Lapatinib - adverse effects | Humans | Risk Factors | Histamine H2 Antagonists - adverse effects | Chemical and Drug Induced Liver Injury - epidemiology | Breast Neoplasms - drug therapy | Cytochrome P-450 CYP3A Inducers - adverse effects | Incidence | Neoplasm Metastasis | Female | Retrospective Studies | Drug Therapy, Combination | Lapatinib - administration & dosage | Aprepitant | Liver cancer | Complications and side effects | Pantoprazole | Liver | Oncology, Experimental | Body weight | Cytochrome P-450 | Metastasis | Research | Risk factors | Cancer | Index Medicus
Journal Article
Nanomedicine, ISSN 1549-9634, 02/2018, Volume 14, Issue 2, pp. 327 - 337
Nanocrystals | Lapatinib | Hyaluronic acid | Tykerb | Triple-negative breast cancer | Science & Technology - Other Topics | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Nanoparticles - chemistry | Lapatinib - chemistry | Hyaluronic Acid - chemistry | Antineoplastic Agents - chemistry | Triple Negative Breast Neoplasms - drug therapy | Lapatinib - pharmacology | Xenograft Model Antitumor Assays | Animals | Triple Negative Breast Neoplasms - metabolism | Triple Negative Breast Neoplasms - pathology | Female | Hyaluronan Receptors - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Mice | Mice, Inbred BALB C | Tumor Cells, Cultured | Antimitotic agents | Breast cancer | Research institutes | Metastasis | Antineoplastic agents | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 11/2019, Volume 19, Issue 1, pp. 1106 - 1106
Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Lapatinib - adverse effects | Humans | Fibroblasts - pathology | Mice, Knockout | Forkhead Box Protein O3 - genetics | Lapatinib - pharmacology | Sirtuin 2 - genetics | Acetylation - drug effects | Drug Resistance, Neoplasm - genetics | Animals | Nasopharyngeal Carcinoma - genetics | Nasopharyngeal Carcinoma - pathology | Fibroblasts - drug effects | Cell Line, Tumor | Nasopharyngeal Carcinoma - drug therapy | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Proteins | Tyrosine | Care and treatment | Carcinoma | Analysis | Metastasis | Health aspects | Acetates | Vincristine | Cancer | Index Medicus | Nasopharyngeal carcinoma | Lapatinib | Acetylation | FOXO3 | Sirtuin | Chemoresistance
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-682X, 3/2019, Volume 76, Issue 6, pp. 1185 - 1199
Life Sciences | Biomedicine, general | Biochemistry, general | Life Sciences, general | Cell-based assay | Lapatinib | Receptor tyrosine kinases | TEV protease | Split TEV recruitment assay | Cell Biology | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | A549 Cells | Reproducibility of Results | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Humans | ErbB Receptors - genetics | Rats | Biological Assay - methods | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | PC12 Cells | Pyrimidines - metabolism | src Homology Domains | Lapatinib - pharmacology | Animals | Lapatinib - metabolism | Receptor Protein-Tyrosine Kinases - genetics | GRB2 Adaptor Protein - genetics | Protein Binding - drug effects | Cell Line, Tumor | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Acrylamides - metabolism | GRB2 Adaptor Protein - metabolism | Acrylamides - pharmacology | Tyrosine | Epidermal growth factor | Proteases | Detectors | Phenols | Psychotherapy | Cells | Phosphotyrosine | Homeostasis | High-throughput screening | Homology | Antagonists | Neurodevelopmental disorders | Cell interactions | Kinases | Assaying | Recruitment | Proteins | Genetic code | Coding | Growth factors | Adaptor proteins | Cell survival | Hepatocyte growth factor | ErbB protein | Adapters | Pharmacology | Insulin | Grb2 protein | Domains | Ligands | Receptor mechanisms | Biosensors | Adapter proteins | Cancer | Index Medicus | Original
Journal Article